Drug
Topical Corticosteroid clinical trials
Keep track of what changes. Save the Topical Corticosteroid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 6
AbbVie (2) · Assiut University (2) · Hams Hamed Abdelrahman (1) · Thomas M. Lietman (1) · Novartis (1) · Jeremy Keenan, MD, MPH (1) · Medical University of Silesia (1)
Often tested with
Tested in the same studies.
Upadacitinib (2) · Vitamin E (1) · Pimecrolimus (1) · Salicylic Acid (1)
Studies
Open first, then newest update. How each study uses Topical Corticosteroid is read from its arms, and is right about nine times in ten.
Testing it · 9
- Parasitic Ulcer Treatment TrialRecruitingPhase 3Jeremy Keenan, MD, MPHNCT06213649Written as Topical corticosteroid
- Photobiomodulation, Photodynamic Therapy, and Clobetasol in the Treatment of Oral Lichen Planus.RecruitingNot applicableMedical University of SilesiaNCT07278999Written as Clobetasol propionate 0.05 percent topical application
- A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisActive, not recruitingPhase 3AbbVieNCT03568318Written as Topical corticosteroids (TCS)
- Adjunctive Oral Systemic Vitamin E Therapy on Salivary Nitric Oxide Level in Patients With Erosive Oral Lichen PlanusCompletedNot applicableHams Hamed AbdelrahmanNCT05787925Written as Topical corticosteroid and Vitamin E
- A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisCompletedPhase 3AbbVieNCT03661138Written as Topical Corticosteroids (TCS)
- Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable VitiligoStatus unknownNot applicableAssiut UniversityNCT03158675Written as Topical corticosteroid
- Steroids for Corneal Ulcers TrialCompletedPhase 4Thomas M. LietmanNCT00324168Written as Topical corticosteroid
- Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of PsoriasisStatus unknownNot applicableAssiut UniversityNCT03156062Written as Topical corticosteroids with salicylic acid
- Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic DermatitisCompletedPhase 4NovartisNCT00121381Written as Pimecrolimus plus topical corticosteroid (TCS)
Given in every arm · 11 — Topical Corticosteroid is usual care beside what is tested
- A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK InhibitorActive, not recruitingPhase 3SanofiNCT06241118Written as Topical corticosteroids
- Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical TrialsActive, not recruitingPhase 2/3SanofiNCT05492578Written as Topical corticosteroids
- Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic DermatitisCompletedPhase 3Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.NCT06554847Written as Topical corticosteroid
- A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical CorticosteroidsCompletedPhase 3SanofiNCT06224348Written as Topical corticosteroids
- A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic DermatitisCompletedPhase 3Eli Lilly and CompanyNCT03952559Written as Topical corticosteroid
- A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisActive, not recruitingPhase 3Eli Lilly and CompanyNCT05559359Written as Topical Corticosteroid (TCS)
- A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically AdvisableCompletedPhase 3Eli Lilly and CompanyNCT03428100Written as Topical corticosteroid
- A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic DermatitisCompletedPhase 3Eli Lilly and CompanyNCT04760314Written as Topical Corticosteroid
- NMF-CsA-Dupi TrialStatus unknownNot applicableErasmus Medical CenterNCT04878770Written as Topical corticosteroids
- Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids AloneTerminatedNot applicableDavid WeinsteinNCT03639857Written as Topical corticosteroid
- A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic DermatitisCompletedPhase 3Eli Lilly and CompanyNCT03733301Written as Topical corticosteroid
As the comparator · 4 — what is tested is compared with Topical Corticosteroid
- Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar PsoriasisNot yet recruitingPhase 4Cairo UniversityNCT07713212Written as Topical Corticosteroid (TCS)
- Role of Tofacitinib in Vitiligo PatientsStatus unknownEarly Phase 1Pi Research Consultancy Center, BangladeshNCT05293119Written as Topical corticosteroid
- 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic DermatitisCompletedPhase 3MEDA Pharma GmbH & Co. KGNCT00120523Written as Topical corticosteroids
- Efficacy of Topical Coal Tar in Children With Atopic DermatitisStatus unknownPhase 4Radboud University Medical CenterNCT03461302Written as Topical corticosteroids